Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response

OBJECTIVES: Three-dimensional organoids derived from primary pancreatic ductal adenocarcinomas are an attractive platform for testing potential anticancer drugs on patient-specific tissue. Optical metabolic imaging (OMI) is a novel tool used to assess drug-induced changes in cellular metabolism, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Alex J., Castellanos, Jason A., Nagathihalli, Nagaraj S., Merchant, Nipun B., Skala, Melissa C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874911/
https://www.ncbi.nlm.nih.gov/pubmed/26495796
http://dx.doi.org/10.1097/MPA.0000000000000543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874911/
https://www.ncbi.nlm.nih.gov/pubmed/26495796
http://dx.doi.org/10.1097/MPA.0000000000000543

Ejemplares similares